Zidovudine

Drug Name : Zidovudine
Indications : Zidovudine is the first approved drug for the treatment of HIV infection. The drug is a competitive inhibitor of HIV reverse transcriptase, which disrupts viral replication because the DNA can no longer elongate.
Normal Values : Not established
Critical Values : Not established
Test Method : High performance liquid chromatography (HPLC), Radio Immunoassay (RIA)
Side effects : hematologic suppression - anemia, leukopenia, granulocytopenia. Hepatic and renal failure.